United Therapeutics
UTHR
#955
Rank
S$32.04 B
Marketcap
S$731.15
Share price
-1.19%
Change (1 day)
94.76%
Change (1 year)

Market capitalization of United Therapeutics (UTHR)

Market cap: S$32.04 Billion

As of April 2026 United Therapeutics has a market cap of S$32.04 Billion. This makes United Therapeutics the world's 955th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of United Therapeutics from 1999 to 2026

End of year Market Cap

Year Marketcap Change
2026S$32.04 B8.82%
2025S$29.44 B34.82%
2024S$21.84 B60.06%
2023S$13.64 B-19.68%
2022S$16.99 B29.15%
2021S$13.15 B47.42%
2020S$8.92 B71.25%
2019S$5.21 B-19.64%
2018S$6.48 B-24.16%
2017S$8.55 B-2.89%
2016S$8.80 B-13.14%
2015S$10.13 B25.77%
2014S$8.06 B11.65%
2013S$7.21 B120.28%
2012S$3.27 B-8.19%
2011S$3.56 B-23.84%
2010S$4.68 B16.95%
2009S$4.00 B92.88%
2008S$2.07 B-33.53%
2007S$3.12 B74.61%
2006S$1.79 B-33.28%
2005S$2.68 B62.44%
2004S$1.65 B98.82%
2003S$0.83 B37.05%
2002S$0.60 B55.55%
2001S$0.38 B-25.39%
2000S$0.52 B-57.38%
1999S$1.22 B

End of Day market cap according to different sources

On Apr 8th, 2026 the market cap of United Therapeutics was reported to be:

S$32.43 Billion
by Nasdaq info icon info icon
S$32.43 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$196.96 B 514.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.087 T 3,293.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S$11.36 B-64.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$224.34 B 600.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
S$64.59 B 101.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$148.33 B 362.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
S$10.11 B-68.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$46.98 B 46.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel